Crip1-flox Mouse
Common Name
Crip1-flox
제품 ID
S-CKO-18201
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-12925-Crip1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Crip1-flox Mouse (카탈로그 번호 S-CKO-18201)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Crip1-flox
품종 계통계통 ID
CKOCMP-12925-Crip1-B6J-VA
유전자명
제품 ID
S-CKO-18201
유전자 별칭
CRHP, CRP1, Crip
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 12
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000006523
NCBI 전사체 ID
NM_007763
타겟 영역
Exon 2~5
유효 영역 크기
~1.6 kb
유전자 연구 개요
CRIP1, also known as cysteine-rich intestinal protein 1, encodes a member of the LIM/double zinc finger protein family. It is involved in regulating diverse cellular processes such as cell growth, development, and differentiation. CRIP1 is associated with multiple signaling pathways including NF-κB, Wnt/β-catenin, and is important in maintaining protein homeostasis [1,2,5,7]. Genetic models, especially KO/CKO mouse models, could potentially offer insights into its functions.
In pancreatic ductal adenocarcinoma (PDAC), CRIP1 upregulation fosters MDSC trafficking and an immunosuppressive tumor microenvironment by facilitating NF-κB/p65 nuclear translocation [1]. In hepatocellular carcinoma (HCC), it promotes cancer stem-like properties by suppressing BBOX1-mediated carnitine metabolism [2]. In gastric cancer, CRIP1 overexpression promotes lymphangiogenesis and lymphatic metastasis by phosphorylating CREB1 and regulating VEGFC and CCL5 expression [3]. In multiple myeloma, high CRIP1 expression is linked to unfavorable outcomes, and it dual-regulates proteasome and autophagy activities [4]. In osteoporosis, reduced CRIP1 expression in bone marrow stromal cells (BMSCs) impairs osteogenic differentiation, while overexpression enhances it via the Wnt signaling pathway [5]. In acute myeloid leukemia (AML), high CRIP1 expression is related to lower remission rates and shorter survival, and in AML-M5 subtype cells, it supports growth and migration by activating the Wnt/β-catenin pathway [6,7]. In gastric cancer, CRIP1 promotes homologous repair upon DNA damage from chemotherapy by cooperating with BRCA2 to enrich nuclear RAD51 [8].
In conclusion, CRIP1 is a crucial regulator in various biological processes and diseases. Through model-based research, its roles in tumorigenesis, immune regulation, bone metabolism, and leukemia development have been revealed. The use of KO/CKO mouse models could further clarify its functions in these disease areas, providing potential therapeutic targets for PDAC, HCC, gastric cancer, multiple myeloma, osteoporosis, and AML.
References：
1. Liu, Xiaomeng, Tang, Rong, Xu, Jin, Yu, Xianjun, Shi, Si. 2023. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma. In Gut, 72, 2329-2343. doi:10.1136/gutjnl-2022-329349. https://pubmed.ncbi.nlm.nih.gov/37541772/
2. Wang, Jing, Zhou, Yan, Zhang, Donghui, Wang, Hui, Zhao, Liang. 2022. CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma. In The EMBO journal, 41, e110218. doi:10.15252/embj.2021110218. https://pubmed.ncbi.nlm.nih.gov/35775648/
3. Wu, Zhonghua, Qu, Bicheng, Yuan, Minxian, Song, Yongxi, Wang, Zhenning. 2023. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303246. doi:10.1002/advs.202303246. https://pubmed.ncbi.nlm.nih.gov/37409440/
4. Tang, Peixia, Yu, Zhen, Sun, Hao, Qiu, Lugui, Hao, Mu. 2024. CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy. In EBioMedicine, 100, 104961. doi:10.1016/j.ebiom.2023.104961. https://pubmed.ncbi.nlm.nih.gov/38199044/
5. Chen, Ruge, Jin, Yangchen, Lian, Ru, Zhang, Zhongmin, Zhao, Liang. 2024. CRIP1 regulates osteogenic differentiation of bone marrow stromal cells and pre-osteoblasts via the Wnt signaling pathway. In Biochemical and biophysical research communications, 727, 150277. doi:10.1016/j.bbrc.2024.150277. https://pubmed.ncbi.nlm.nih.gov/38936225/
6. Ma, Bei-Bei, Zhang, Ting-Juan, Wang, Cui-Zhu, Lin, Jiang, Qian, Jun. 2020. Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia. In American journal of translational research, 12, 4840-4852. doi:. https://pubmed.ncbi.nlm.nih.gov/33042393/
7. Deng, Xiaoling, Zeng, Yanmei, Qiu, Xiaofen, Zhang, Jingdong, Chen, Xiaoli. 2023. CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway. In Leukemia research, 130, 107312. doi:10.1016/j.leukres.2023.107312. https://pubmed.ncbi.nlm.nih.gov/37224580/
8. Sun, Huiying, Zhou, Rui, Zheng, Yannan, Shi, Min, Liao, Wangjun. 2021. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. In Oncogene, 40, 5342-5355. doi:10.1038/s41388-021-01932-0. https://pubmed.ncbi.nlm.nih.gov/34262130/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.